Literature DB >> 19608181

Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period.

Shayan Irani1, Andrew Arai, Kamran Ayub, Thomas Biehl, John J Brandabur, Russell Dorer, Michael Gluck, Geoffrey Jiranek, David Patterson, Drew Schembre, L William Traverso, Richard A Kozarek.   

Abstract

BACKGROUND: Tumors arising from the duodenal papilla account for approximately 5% of GI neoplasms, but are increasingly identified.
OBJECTIVE: To describe the clinical characteristics and outcomes in a large single-center experience with patients referred for ampullary lesions.
DESIGN: A retrospective review of the Virginia Mason Medical Center endoscopy and hospital service database.
SETTING: Tertiary referral center. PATIENTS: One hundred ninety-three patients referred for ampullary lesions from 1997 to 2007.
INTERVENTIONS: Endoscopic management of ampullary lesions. MAIN OUTCOME MEASUREMENTS: The relationship of demographic and clinical data with endoscopic treatment and clinical outcomes in these patients.
RESULTS: One hundred ninety-three patients underwent endoscopy for ampullary lesions. Fifteen juxta-ampullary lesions and 10 normal variants were excluded. Among 168 patients, there were 112 (67%) adenomas, 38 (23%) adenocarcinomas, and 18 (10%) nonadenomatous lesions. There were 88 men and 80 women, with a mean age of 64 years. Clinical presentation included cholestasis/cholangitis (72 patients), abdominal pain (54 patients), incidental/asymptomatic (51 patients), pancreatitis (9 patients), and bleeding (7 patients). Of the 57 patients referred to surgery, 42 were sent directly without papillectomy, and 16 were sent after papillectomy. Papillectomies were performed in 102 patients with adenomatous lesions. The mean tumor size was 2.4 cm (range 0.5-6 cm). The papillectomy complication rate was 21%: mild pancreatitis in 10 (10%) patients, cholangitis in 1, retroperitoneal perforation in 1 (adenocarcinoma), intraperitoneal perforation in 1 (lateral extension), bleeding in 5 (lateral extension in 2 of these 5), and delayed papillary stenosis in 3. Recurrences were seen in 8%. The endoscopic success rate was 84%. Factors affecting success were a smaller adenoma size and the absence of dilated ducts.
CONCLUSIONS: Most ampullary adenomas are amenable to endoscopy. Underlying malignancy and lateral extension may be risk factors for bleeding and perforation. Smaller lesion size and the absence of dilated ducts are factors favorably affecting success.

Entities:  

Mesh:

Year:  2009        PMID: 19608181     DOI: 10.1016/j.gie.2009.04.015

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  49 in total

Review 1.  Endoscopic management of adenomatous ampullary lesions.

Authors:  Jesús Espinel; Eugenia Pinedo; Vanesa Ojeda; Maria Guerra Del Rio
Journal:  World J Methodol       Date:  2015-09-26

2.  Endoscopic ampullectomy: a practical guide.

Authors:  Milan Bassan; Michael Bourke
Journal:  J Interv Gastroenterol       Date:  2012-01-01

3.  Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up.

Authors:  Wim Laleman; Annelies Verreth; Baki Topal; Raymond Aerts; Mina Komuta; Tania Roskams; Schalk Van der Merwe; David Cassiman; Frederik Nevens; Chris Verslype; Werner Van Steenbergen
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

4.  Can papillary carcinomas be treated by endoscopic ampullectomy?

Authors:  Saïda Salmi; Salah Ezzedine; Veronique Vitton; Charles Ménard; Jean-Michel Gonzales; Ariadne Desjeux; Jean-Charles Grimaud; Marc Barthet
Journal:  Surg Endosc       Date:  2011-10-20       Impact factor: 4.584

5.  Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome.

Authors:  Tianle Ma; Eun Jeong Jang; Lawrence R Zukerberg; Robert Odze; Manish K Gala; Peter B Kelsey; David G Forcione; William R Brugge; Brenna W Casey; Sapna Syngal; Daniel C Chung
Journal:  Surg Endosc       Date:  2014-02-25       Impact factor: 4.584

Review 6.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

7.  Robotic surgery for benign duodenal tumors.

Authors:  Stephanie Downs-Canner; Wald J Van der Vliet; Stijn J J Thoolen; Brian A Boone; Amer H Zureikat; Melissa E Hogg; David L Bartlett; Mark P Callery; Tara S Kent; Herbert J Zeh; A James Moser
Journal:  J Gastrointest Surg       Date:  2014-10-28       Impact factor: 3.452

8.  Endoscopic papillectomy for neoplastic ampullary lesions: A systematic review with pooled analysis.

Authors:  Marco Spadaccini; Alessandro Fugazza; Leonardo Frazzoni; Milena Di Leo; Francesco Auriemma; Silvia Carrara; Roberta Maselli; Piera Alessia Galtieri; Viveksandeep Thoguluva Chandrasekar; Lorenzo Fuccio; Emad Aljahdli; Cesare Hassan; Prateek Sharma; Andrea Anderloni; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2019-07-30       Impact factor: 4.623

Review 9.  Endoscopic papillectomy: indications, techniques, and results.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution.

Authors:  Yuichiro Watanabe; Hideyuki Ishida; Hiroyuki Baba; Takeo Iwama; Atsushi Kudo; Minoru Tanabe; Hideki Ishikawa
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.